©The Author(s) 2022.
World J Hepatol. Jul 27, 2022; 14(7): 1398-1407
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1398
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1398
Table 2 Univariate analysis on time to development of death/clinical deterioration prior to liver transplant
| Variable | n | Events | Cox univariate hazard ratio (95%CI) | P value |
| Age | 265 | 68 (26%) | 1.018 (0.985, 1.053) | 0.28 |
| Sex | ||||
| Female | 137 | 38 (28%) | - | |
| Male | 128 | 30 (23%) | 0.84 (0.52, 1.37) | 0.49 |
| Model for End-Stage Liver Disease | 265 | 68 (26%) | 1.18 (1.14, 1.23) | < 0.001 |
| Body mass index | 265 | 68 (26%) | 0.975 (0.941, 1.011) | 0.17 |
| Renal replacement therapy | ||||
| No | 233 | 60 (26%) | - | |
| Yes | 32 | 8 (25%) | 3.20 (1.49, 6.88) | 0.003 |
| Hypertension | ||||
| No | 113 | 29 (26%) | - | |
| Yes | 152 | 39 (26%) | 1.15 (0.71, 1.88) | 0.57 |
| Obstructive sleep apnea | ||||
| No | 203 | 46 (23%) | - | |
| Yes | 62 | 22 (35%) | 1.10 (0.66, 1.85) | 0.72 |
| Atrial fibrillation/Atrial flutter | ||||
| No | 256 | 64 (25%) | - | |
| Yes | 8 | 3 (38%) | 2.97 (0.92, 9.61) | 0.069 |
| Heart failure | . | |||
| No | 244 | 60 (25%) | - | |
| Yes | 18 | 8 (44%) | 1.81 (0.86, 3.82) | 0.12 |
| Left ventricular ejection fraction | 263 | 67 (25%) | 0.99 (0.96, 1.03) | 0.69 |
| Estimated right ventricular systolic pressure | 190 | 48 (25%) | 1.026 (0.997, 1.055) | 0.075 |
| Aortic stenosis | ||||
| No | 257 | 67 (26%) | - | |
| Yes | 8 | 1 (13%) | 0.95 (0.13, 6.86) | 0.96 |
| Aortic insufficiency | ||||
| No | 263 | 67 (25%) | - | |
| Yes | 2 | 1 (50%) | 1.38 (0.19, 10.04) | 0.75 |
| Mitral regurgitation | ||||
| No | 261 | 67 (26%) | - | |
| Yes | 4 | 1 (25%) | 2.92 (0.40, 21.48) | 0.29 |
| Tricuspid regurgitation | ||||
| No | 257 | 64 (25%) | - | |
| Yes | 8 | 4 (50%) | 3.50 (1.26, 9.72) | 0.016 |
| CAD | ||||
| No significant CAD | 196 | 44 (22%) | - | |
| Mild or Moderate CAD | 45 | 15 (33%) | 2.06 (1.14, 3.74) | 0.017 |
| Severe CAD | 24 | 9 (38%) | 2.43 (1.17, 5.05) | 0.017 |
| History of myocardial infarction | ||||
| No | 253 | 63 (25%) | - | |
| Yes | 12 | 5 (42%) | 2.29 (0.92, 5.74) | 0.076 |
| History of coronary artery stenting | ||||
| No | 252 | 63 (25%) | - | |
| Yes | 13 | 5 (38%) | 1.86 (0.74, 4.66) | 0.19 |
| History of coronary artery bypass grafting | ||||
| No | 254 | 64 (25%) | - | |
| Yes | 11 | 4 (36%) | 2.03 (0.73, 5.65) | 0.17 |
| Hemoglobin A1c | ||||
| < 5.6 | 59 | 12 (20%) | - | - |
| 5.6-6.5 | 62 | 19 (31%) | 1.11 (0.53, 2.32) | 0.79 |
| > 6.5 | 50 | 15 (30%) | 0.80 (0.37, 1.76) | 0.58 |
| High-density lipoprotein | ||||
| ≥ 50 | 75 | 22 (29%) | - | |
| < 50 | 176 | 41 (23%) | 1.18 (0.69, 2.01) | 0.54 |
| Triglycerides | ||||
| ≤ 150 | 240 | 63 (26%) | - | |
| > 150 | 15 | 2 (13%) | 0.49 (0.12, 2.00) | 0.32 |
- Citation: Delicce M, Mauch J, Joseph A, Lyu R, Kren H, Bartow R, Ferchill D, Fares M, Wakim-Fleming J. Cardiac risk factors limiting survival to liver transplantation in patients with nonalcoholic fatty liver disease. World J Hepatol 2022; 14(7): 1398-1407
- URL: https://www.wjgnet.com/1948-5182/full/v14/i7/1398.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i7.1398